LPL Financial
NTLA icon

LPL Financial’s Intellia Therapeutics NTLA Stock Holding History

LPL Financial’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Buy
191,480
+68,619
+56% +$960K ﹤0.01% 3225
2026
Q1 		$1.58M Buy
122,861
+2,564
+2% +$32.7K ﹤0.01% 3729
2025
Q4 		$1.08M Buy
120,297
+17,262
+17% +$238K ﹤0.01% 3992
2025
Q3 		$1.78M Buy
103,035
+39,082
+61% +$481K ﹤0.01% 3419
2025
Q2 		$600K Buy
63,953
+9,249
+17% +$76K ﹤0.01% 4226
2025
Q1 		$389K Buy
54,704
+663
+1% +$6.7K ﹤0.01% 4389
2024
Q4 		$630K Sell
54,041
-2,554
-5% -$39.9K ﹤0.01% 3891
2024
Q3 		$1.16M Sell
56,595
-731
-1% -$16.9K ﹤0.01% 3252
2024
Q2 		$1.28M Buy
57,326
+5,735
+11% +$137K ﹤0.01% 3016
2024
Q1 		$1.42M Buy
51,591
+5,055
+11% +$140K ﹤0.01% 2865
2023
Q4 		$1.42M Buy
46,536
+1,738
+4% +$50K ﹤0.01% 2725
2023
Q3 		$1.42M Buy
44,798
+219
+0.5% +$8.5K ﹤0.01% 2601
2023
Q2 		$1.82M Buy
44,579
+5,998
+16% +$243K ﹤0.01% 2336
2023
Q1 		$1.44M Buy
38,581
+2,590
+7% +$102K ﹤0.01% 2445
2022
Q4 		$1.26M Sell
35,991
-3,776
-9% -$180K ﹤0.01% 2464
2022
Q3 		$2.23M Sell
39,767
-2,056
-5% -$128K ﹤0.01% 1898
2022
Q2 		$2.17M Buy
41,823
+912
+2% +$46.3K ﹤0.01% 1964
2022
Q1 		$2.97M Sell
40,911
-3,732
-8% -$316K ﹤0.01% 1762
2021
Q4 		$5.28M Buy
44,643
+891
+2% +$112K ﹤0.01% 1427
2021
Q3 		$5.87M Buy
43,752
+1,817
+4% +$275K 0.01% 1292
2021
Q2 		$6.79M Sell
41,935
-11,826
-22% -$921K 0.01% 1140
2021
Q1 		$4.32M Buy
53,761
+10,454
+24% +$702K 0.01% 1324
2020
Q4 		$2.36M Buy
43,307
+12,460
+40% +$452K ﹤0.01% 1570
2020
Q3 		$613K Buy
30,847
+4,406
+17% +$91.9K ﹤0.01% 2310
2020
Q2 		$556K Buy
26,441
+14,409
+120% +$245K ﹤0.01% 2299
2020
Q1 		$147K Buy
+12,032
New +$162K ﹤0.01% 2902

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

LPL Financial's NTLA Position: Q2 2026 in Review

LPL Financial increased its Intellia Therapeutics (NTLA) stake by 56% in Q2 2026, buying an estimated $960K and bringing the position to 191,480 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3225.

LPL Financial first reported a position in NTLA in Q1 2020 and has held it in 26 quarters since. The position peaked at $6.79M in Q2 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • LPL Financial held 191,480 shares of Intellia Therapeutics worth $3.24M as of Q2 2026.
  • LPL Financial bought 68,619 Intellia Therapeutics shares in Q2 2026, an estimated $960K.
  • Intellia Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3225 holding.
  • LPL Financial first reported a position in Intellia Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • LPL Financial's Intellia Therapeutics position peaked at $6.79M in Q2 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.